Loading...

PerCP/Cyanine5.5 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PerCPCyanine55_CD45_Antibody_082418
C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
  • 30-F11_PerCPCyanine55_CD45_Antibody_082418
    C57BL/6 mouse splenocytes were stained with CD45 (Clone 30-F11) PerCP/Cyanine5.5 (filled histogram), or rat IgG2b, κ PerCP/Cyanine5.5 isotype control (open histogram).
See PerCP/Cyanine5.5 spectral data
Cat # Size Price Save
103131 25 µg ¥15,490
103132 100 µg ¥39,340
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  2. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  3. Baron CS, et al. 2018. Nat Commun. 9:2517. PubMed
  4. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  5. Klose A, et al. 2018. JCSM Rapid Commun. 9:20222. PubMed
  6. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  7. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  8. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  9. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  10. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  11. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  12. Liang Z, et al. 2017. Autophagy. 14:505. PubMed
  13. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  14. Biffi G, et al. 2018. Cancer Discov. 2:282. PubMed
  15. Han Y, et al. 2019. J Clin Invest. 130:26. PubMed
  16. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  17. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  18. Mitchell LA, et al. 2019. Oncotarget. 10:2252. PubMed
  19. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  20. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  21. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  22. Christ A, et al. 2018. Cell. 172:162. PubMed
  23. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  24. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  25. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  26. Böhm AM et al. 2019. Dev Cell. 51(2):236-254 . PubMed
  27. Adrover JM et al. 2019. Immunity. 50(2):390-402 . PubMed
  28. Du Q et al. 2019. Dev Cell. 49(4):618-631 . PubMed
  29. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  30. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  31. Caronni N, et al. 2018. Cancer Res. 78:1685. PubMed
  32. Bernstock JD, et al. 2019. J Allergy Clin Immunol. 145:358. PubMed
  33. Wang L, et al. 2020. Nat Commun. 0.654166667. PubMed
  34. Haider N, et al. 2020. Cell Commun Signal. 18:26. PubMed
  35. Casanova-Acebes M, et al. 2018. J Exp Med. 215:2778. PubMed
  36. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  37. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  38. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  39. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  40. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  41. Miragaia RJ, et al. 2018. Sci Rep. 8:685. PubMed
  42. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  43. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  44. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  45. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
  46. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  47. Garcia–Agudo LF, et al. 2019. FASEB J. :fj201900337R. PubMed
  48. Horiguchi H, et al. 2019. Genes Dev. 33:1641. PubMed
  49. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  50. Nicholas DA, et al. 2020. Scientific Reports. 10(1):13063. PubMed
  51. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  52. Branchett WJ, et al. 2020. Wellcome Open Research. 0.278472222. PubMed
  53. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  54. Scott NA, et al. 2018. Front Immunol. 2.319444444. PubMed
  55. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  56. Liu Z, et al. 2015. Development. 142: 2452 - 2463. PubMed
  57. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  58. Fleury M, et al. 2015. Development. 142: 3307 - 3320. PubMed
  59. Sun L, et al. 2015. Sci Rep. 5: 14871. PubMed
  60. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  61. Patel K, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.11. PubMed
  62. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  63. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  64. Garcia-Alegria E, et al. 2016. Sci Rep. 6: 25917. PubMed
  65. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  66. Chandra J, et al. 2016. Immunol Cell Biol. 10.1038/icb.2016.83. PubMed
  67. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  68. Browning D, et al. 2017. Gene Ther. 10.1038/gt.2016.88. PubMed
  69. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  70. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  71. Wang Y, et al. 2020. Cell Death Dis. 1.169444444. PubMed
  72. Martomo SA, et al. 2021. Mol Cancer Ther. 1.074305556. PubMed
  73. Choi JG, et al. 2020. Front Immunol. 11:598556. PubMed
  74. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  75. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  76. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  77. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  78. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  79. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  80. Caporarello N, et al. 2020. Aging Cell. 19:e13196. PubMed
  81. Krausgruber T, et al. 2020. Nature. 583:296. PubMed
  82. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  83. Bayik D, et al. 2020. Cancer Discov. 1.256944444. PubMed
  84. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  85. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  86. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  87. Hsu CY, et al. 2020. Frontiers in Immunology. 11:574839. PubMed
  88. Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed
  89. Li N, et al. 2021. eLife. 10:00. PubMed
  90. Omori S, et al. 2020. Cell Metabolism. 32(5):814-828.e6. PubMed
  91. Ballesteros I, et al. 2020. Cell. 183(5):1282-1297.e18. PubMed
  92. Daemen S, et al. 2021. Cell Reports. 34(2):108626. PubMed
  93. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  94. Shao M, et al. 2021. Cell Stem Cell. 28(4):685-701.e7. PubMed
  95. Joffin N, et al. 2021. Cell Stem Cell. 28(4):702-717.e8. PubMed
  96. Yu M, et al. 2021. Molecular Cell. 81(6):1216-1230.e9. PubMed
  97. Doss PMIA, et al. 2021. Cell Reports. 34(10):108833. PubMed
  98. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  99. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  100. Wang C, et al. 2021. Cell Stem Cell. . PubMed
  101. Peng Z, et al. 2021. STAR Protocols. 2(2):100595. PubMed
  102. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  103. Osborne JK, et al. 2021. Cell Reports. 36(3):109408. PubMed
  104. Zaman R, et al. 2021. Immunity. :. PubMed
  105. Liu SS, et al. 2021. Immunity. :. PubMed
  106. Mesnieres M, et al. 2021. Cell Reports. 36(8):109618. PubMed
  107. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  108. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  109. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  110. Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
  111. Ko HJ, et al. 2020. Front Immunol. 1897:11. PubMed
  112. Damal Villivalam S, et al. 2020. Nat Commun. 4313:11. PubMed
  113. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  114. Wei SC, et al. 2020. Cancer Discov. . PubMed
  115. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  116. Weinstock A, et al. 2021. Elife. :10. PubMed
  117. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  118. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  119. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
  120. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  121. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  122. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  123. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  124. Sheriff L, et al. 2020. Dis Model Mech. 13:dmm046383. PubMed
  125. Steele NG, et al. 2021. Clin Cancer Res. 27:2023. PubMed
  126. Li Z, et al. 2021. Immunology. 163:105. PubMed
  127. Voisin M, et al. 2021. Commun Biol. 4:420. PubMed
  128. Zhang Q, et al. 2021. Front Cell Dev Biol. 9:655552. PubMed
  129. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  130. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  131. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  132. Calle P, et al. 2021. Cells. 10:. PubMed
  133. Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
  134. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  135. Pizzurro GA, et al. 2021. Cancers (Basel). 13:. PubMed
  136. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  137. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  138. Tuong ZK, et al. 2021. iScience. 24:103326. PubMed
  139. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  140. Craver BM, et al. 2020. Blood Adv. 4:312. PubMed
  141. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  142. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  143. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  144. Yu H, et al. 2021. Cell Death Dis. 13:1. PubMed
  145. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  146. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  147. Toth K, et al. 2022. PLoS Biol. 20:e3001526. PubMed
  148. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  149. Karolin A, et al. 2022. Front Pharmacol. 12:789080. PubMed
  150. Krueger A, et al. 2022. Front Microbiol. 12:789042. PubMed
  151. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  152. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  153. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  154. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  155. Peres-Emidio EC, et al. 2022. Front Cell Infect Microbiol. 12:811474. PubMed
  156. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  157. Lang V, et al. 2021. Elife. 10:. PubMed
  158. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  159. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  160. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  161. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  162. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  163. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
  164. Yang Z, et al. 2021. Sci Adv. 7:. PubMed
  165. Sánchez-del-Campo L, et al. 2021. J Exp Clin Cancer Res. 40:117. PubMed
  166. Jazowiecka-Rakus J, et al. 2021. Cancers (Basel). 13:. PubMed
  167. Mittal A, et al. 2021. Sci Rep. 11:10731. PubMed
  168. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  169. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  170. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  171. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  172. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  173. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  174. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
  175. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  176. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  177. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  178. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  179. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  180. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  181. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  182. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
  183. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  184. Thomas K, et al. 2022. JCI Insight. :. PubMed
  185. Mello AM, et al. 2022. Oncogenesis. 11:56. PubMed
  186. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  187. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  188. Jazowiecka-Rakus J, et al. 2020. Mol Ther Oncolytics. 18:335. PubMed
  189. Liang Z, et al. 2021. J Cell Physiol. 236:4725. PubMed
  190. Vogiatzi A, et al. 2021. Mol Cell Biol. 41:e0014921. PubMed
  191. Timblin GA, et al. 2021. Nat Metab. 3:618. PubMed
  192. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
  193. Pani F, et al. 2021. Endocrinology. 162:. PubMed
  194. Fernandez Garcia-Agudo L, et al. 2021. Cell Rep. 36:109548. PubMed
  195. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  196. Cong M, et al. 2021. Methods Mol Biol. 2388:59. PubMed
  197. Golden GJ, et al. 2021. MBio. 12:e0118121. PubMed
  198. Coleby R, et al. 2021. Clin Exp Rheumatol. :39. PubMed
  199. Padonou F, et al. 2022. EMBO Rep. 23:e53576. PubMed
  200. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  201. Lee J, et al. 2022. Nat Commun. 13:1516. PubMed
  202. Xiong W, et al. 2022. Nat Commun. 13:1700. PubMed
  203. Chimenti I, et al. 2022. Cell Death Discov. 8:149. PubMed
  204. Wang W, et al. 2022. Aging Cell. 21:e13630. PubMed
  205. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  206. Rosen SF, et al. 2022. Genome Med. 14:108. PubMed
  207. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  208. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  209. Shen H, et al. 2022. Nat Commun. 13:6030. PubMed
  210. Sakaguchi M, et al. 2022. Nat Commun. 13:6092. PubMed
  211. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  212. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  213. Jung IY, et al. 2022. Sci Transl Med. 14:eabn7336. PubMed
  214. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  215. Xuan W, et al. 2022. Cancer Immunol Res. 10:770. PubMed
  216. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  217. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  218. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  219. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  220. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  221. VanDyke D, et al. 2022. Cell Rep. 41:111478. PubMed
  222. Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed
  223. Lai C, et al. 2023. J Bone Miner Res. 38:86. PubMed
  224. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  225. Xu H, et al. 2022. Aging Dis. 13:1875. PubMed
  226. Zha AH, et al. 2022. Lupus Sci Med. 9: . PubMed
  227. Guo J, et al. 2023. Cell Rep Med. 4:100881. PubMed
  228. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  229. Liu G, et al. 2023. Commun Biol. 6:102. PubMed
  230. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  231. Kuehm LM, et al. 2021. Cancer Immunol Res. 9:227. PubMed
  232. Khan NZ, et al. 2021. Brain Behav Immun. 92:165. PubMed
  233. Na E, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L550. PubMed
  234. Tang Y, et al. 2022. Dev Cell. 57:480. PubMed
  235. Li X, et al. 2022. Cell. 185:1709. PubMed
  236. Zhang Q, et al. 2022. Nat Metab. 4:1055. PubMed
  237. Bermea KC, et al. 2022. J Vis Exp. . PubMed
  238. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  239. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  240. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  241. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  242. Fei F, et al. 2022. Int J Mol Sci. 23:. PubMed
  243. Shi H, et al. 2022. Nutrients. 14:. PubMed
  244. Li J, et al. 2022. Elife. 11:. PubMed
  245. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  246. Xiao Y, et al. 2023. EMBO J. 42:e111762. PubMed
  247. He Y, et al. 2023. Biomolecules. 13:. PubMed
  248. Zhang Z, et al. 2023. Aging Dis. 14:966. PubMed
  249. Doloff JC, et al. 2023. Sci Adv. 9:eade9488. PubMed
RRID
AB_893344 (BioLegend Cat. No. 103131)
AB_893340 (BioLegend Cat. No. 103132)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Go To Top Version: 3    Revision Date: 08/24/2018

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account